Unihealth Hospitals Limited H1 profit rises to Rs 21.5236 crore
Key highlights
- Unihealth reported consolidated profit of Rs 21.5236 crore for the half year ended September 30, 2026, versus Rs 17.0941 crore in the preceding half.
- Uganda generated Rs 23.8552 crore of segment profit before tax on revenue of Rs 64.2709 crore in the September 2026 half.
- Total assets increased to Rs 326.4556 crore at September 30, 2026 from Rs 254.1602 crore at March 31, 2026.
- Unihealth reported investing cash outflow of Rs 74.4512 crore, including Rs 74.8722 crore spent on property, plant and equipment.
powered by IRIS

Unihealth Hospitals Limited reported consolidated profit of Rs 21.5236 crore for the half year ended September 30, 2026, up from Rs 17.0941 crore in the preceding half, while Uganda contributed Rs 23.8552 crore of segment profit before tax. Profit nevertheless remained below Rs 28.6318 crore reported for the half year ended September 30, 2025.
Know Unihealth Hospitals inside out
Results, valuation, peers and who's buying, in one view.
How did Unihealth’s profit and revenue change?
Unihealth’s consolidated profit increased sequentially by Rs 4.4295 crore to Rs 21.5236 crore in the half year ended September 30, 2026, from Rs 17.0941 crore in the half year ended March 31, 2026. Compared with the corresponding September 2025 half, however, profit declined by Rs 7.1082 crore from Rs 28.6318 crore.
Revenue from operations rose to Rs 76.4445 crore from Rs 65.3221 crore in the March 2026 half and Rs 66.6662 crore a year earlier. Including other income, total revenue was Rs 77.7781 crore, against Rs 67.4481 crore sequentially and Rs 69.5642 crore in the September 2025 half. Profit before tax was Rs 18.3386 crore, above Rs 16.7069 crore in the preceding half but below Rs 29.5872 crore a year earlier.
A net tax credit of Rs 3.2877 crore helped lift profit above pre-tax profit in the September 2026 half. The tax line included current tax of Rs 80.61 lakh, deferred-tax income of Rs 4.2523 crore and a Rs 15.85 lakh short or excess provision of earlier years. Unihealth also recorded a Rs 10.27 lakh loss from its associate.
How did Unihealth’s geographic segments perform?
Uganda remained Unihealth’s main earnings contributor, reporting segment profit before tax of Rs 23.8552 crore for the half year ended September 30, 2026. This was up from Rs 15.1980 crore in the March 2026 half, but below Rs 28.4977 crore in the September 2025 half. Uganda’s segment revenue increased to Rs 64.2709 crore from Rs 52.0257 crore sequentially and Rs 63.2431 crore a year earlier.
India recorded a segment loss before tax of Rs 33.07 lakh, improving from a Rs 2.8249 crore loss in the preceding half but reversing from a Rs 1.9165 crore profit in the September 2025 half. India’s revenue was Rs 15.5006 crore, slightly below Rs 15.9612 crore sequentially but above Rs 8.9886 crore a year earlier. Tanzania posted a Rs 5.41 lakh loss, Nigeria reported Rs 4 lakh of profit, and Mauritius generated Rs 1.3038 crore of profit before tax.
The United Arab Emirates segment generated Rs 61.85 lakh of revenue and Rs 56.40 lakh of profit before tax, compared with Rs 4.4224 crore of revenue and Rs 4.2546 crore of profit in the March 2026 half. Total segment revenue before eliminations was Rs 82.3378 crore, while inter-segment revenue fell to Rs 4.5597 crore from Rs 5.6461 crore in the preceding half.
Why did Unihealth’s assets and liabilities change?
Unihealth’s consolidated assets rose to Rs 326.4556 crore at September 30, 2026 from Rs 254.1602 crore at March 31, 2026. Property, plant and equipment increased to Rs 92.0215 crore from Rs 64.9426 crore, while right-of-use assets increased to Rs 60.9832 crore from Rs 10.9235 crore. Capital work in progress declined to Rs 1.1226 crore from Rs 9.6086 crore over the same period.
India accounted for Rs 267.5588 crore of segment assets at September 30, 2026, up from Rs 127.6650 crore at March 31, while Uganda accounted for Rs 168.0908 crore, compared with Rs 163.2879 crore. Consolidated assets were lower than total segment assets because inter-segment eliminations rose to Rs 143.1802 crore from Rs 68.0913 crore. Trade receivables declined to Rs 114.3931 crore from Rs 123.3795 crore, while cash and cash equivalents increased to Rs 12.1728 crore from Rs 10.4463 crore.
Total liabilities increased to Rs 110.0329 crore from Rs 56.2021 crore in the six months to September 30, 2026. Non-current liabilities rose to Rs 81.9530 crore from Rs 26.9788 crore, including lease liabilities of Rs 58.8195 crore versus Rs 9.2633 crore and borrowings of Rs 22.6769 crore versus Rs 16.0943 crore. Total equity increased to Rs 216.4227 crore from Rs 159.5814 crore, including non-controlling interest of Rs 67.6556 crore.
Got a follow-up? Ask IRIS
What did Unihealth’s cash flow and accounting change show?
Unihealth generated net operating cash flow of Rs 23.8273 crore in the half year ended September 30, 2026, compared with Rs 5.6926 crore for the full year ended March 31, 2026. Operating profit before working-capital changes was Rs 25.0155 crore, and net working-capital changes used Rs 23.74 lakh. A Rs 8.9864 crore decrease in trade receivables partly offset an Rs 8.1959 crore increase in other financial assets and other current assets.
Investing activities used Rs 74.4512 crore during the half, principally because Unihealth reported Rs 74.8722 crore of purchases of property, plant and equipment. Net financing cash inflow was Rs 52.0319 crore, and cash and cash equivalents rose by Rs 1.4080 crore to Rs 12.1728 crore. The comparative March 2026 cash-flow figures cover a full financial year rather than a six-month period.
A depreciation-estimate revision at subsidiary UMC Hospitals Private Limited increased the reported September 2026 half-year result. The subsidiary changed depreciation for a building classified as a right-of-use asset from the written-down-value method to the straight-line method, lowering depreciation by Rs 28.92 lakh and increasing profit after tax by Rs 14.32 lakh. The statutory auditor issued an unmodified review conclusion while drawing attention to the revision.
How is Unihealth using its IPO proceeds?
Unihealth reported no deviation or variation in use of its Rs 56.5488 crore initial public offering proceeds for the half year ended September 30, 2026. The company had fully utilised Rs 17 crore allocated to Victoria Hospital Limited in Kampala, Uganda, for its capital expenditure and working-capital requirements.
Unihealth had utilised Rs 2.9030 crore of the Rs 4.60 crore originally allocated to UMC Global Health Limited in Nigeria, leaving Rs 1.6970 crore unutilised. The allocation for Biohealth Limited in Tanzania was changed to Rs 2.3750 crore from Rs 15.8750 crore, with Rs 13.50 crore reallocated to UMC Hospitals Private Limited in India and Unihealth Holdings Limited in Mauritius for expansion and acquisition projects across India and Africa.
The company stated that shareholders approved the reallocation through a resolution passed on June 26, 2024. Its filing said the Audit Committee had no comments after reviewing the proceeds statement on November 14, 2026, and the statutory auditor’s certificate was approved by the committee on the same date.
Conclusion
Unihealth delivered higher sequential consolidated revenue and profit in the September 2026 half, although both Uganda’s segment profit and group profit remained below the corresponding September 2025 period. Uganda supplied Rs 23.8552 crore of the group’s Rs 18.3386 crore pre-tax profit, while India narrowed its sequential segment loss and the balance sheet expanded through higher property, right-of-use assets and lease liabilities.
The next disclosures to watch are utilisation of the remaining Rs 1.6970 crore Nigeria allocation and progress on the stated expansion and acquisition plans supported by the Rs 13.50 crore India-Mauritius reallocation. Later results will also show the continuing comparability effect of the depreciation-method revision, which added Rs 14.32 lakh to September 2026 half-year profit after tax.


